Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / ADS
-
Total 13F shares
-
1,955,799
-
Share change
-
-305,634
-
Total reported value
-
$39,359,000
-
Price per share
-
$20.61
-
Number of holders
-
7
-
Value change
-
-$5,425,406
-
Number of buys
-
3
-
Number of sells
-
2
Institutional Holders of Silence Therapeutics plc - ADS (SLN) as of Q3 2021
As of 30 Sep 2021,
Silence Therapeutics plc - ADS (SLN) was held by
7 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,955,799 shares.
The largest 7 holders included
BVF INC/IL, Lombard Odier Asset Management (USA) Corp, ADAGE CAPITAL PARTNERS GP, L.L.C., Consonance Capital Management LP, BLAIR WILLIAM & CO/IL, SG Americas Securities, LLC, and MORGAN STANLEY.
This page lists
7
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.